iOS · Coming 2026
Lirava
Private guidance for sensitive healing journeys. Track your recovery, understand your patterns, and walk into every appointment prepared.
Join the early access list
Private guidance for sensitive healing journeys. Track your recovery, understand your patterns, and walk into every appointment prepared.
Join the early access list
Lirava asks you a handful of questions each day. No forms, no pressure. Over time it builds a picture of your recovery — and turns that picture into a concise clinical summary you can share at your next appointment.
A brief daily log — under a minute — that captures the signals that matter for recovery. What changed, what didn't, what you noticed.
One page. Chronological. Readable by a clinician in thirty seconds. No graphs, no jargon, no noise — just what your doctor needs.
Your data stays on your phone. No account required. No cloud sync unless you choose to export. We can't see your health records because we don't receive them.
No streaks. No scores. No notifications urging you to "stay on track." Recovery isn't a habit loop. Lirava doesn't pretend it is.
Each day, answer a short set of questions about your symptoms, diet, and any changes you noticed. It takes less than a minute.
Lirava shows you patterns in your own data — without alarm, without judgment. Your recovery has context. It deserves to be read that way.
Before your appointment, generate a one-page clinical summary. Print it or share it. Your doctor gets the full picture in seconds.
Lirava is built for adults recovering from gut and anorectal conditions — conditions that are common, under-discussed, and often managed across multiple appointments over months or years.
Lirava is a tracking and education companion. It does not diagnose, prescribe, or replace clinical care.
If you are in acute pain or believe you need urgent care, contact your doctor or go to an emergency room. Lirava is for the long stretches in between — the daily work of recovery that rarely fits into a ten-minute appointment.
Lirava is in development. We're building carefully and won't rush it. Join the list and we'll reach out when launch is close.